These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12747948)

  • 1. Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells.
    Sartorius R; D'Apice L; Barba P; Guardiola J; Santoni A; Velotti F; De Berardinis P
    Cell Immunol; 2003 Feb; 221(2):81-8. PubMed ID: 12747948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen.
    Vankayalapati R; Klucar P; Wizel B; Weis SE; Samten B; Safi H; Shams H; Barnes PF
    J Immunol; 2004 Jan; 172(1):130-7. PubMed ID: 14688318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+ B cells.
    Blanca IR; Bere EW; Young HA; Ortaldo JR
    J Immunol; 2001 Dec; 167(11):6132-9. PubMed ID: 11714772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells.
    Turner JG; Rakhmilevich AL; Burdelya L; Neal Z; Imboden M; Sondel PM; Yu H
    J Immunol; 2001 Jan; 166(1):89-94. PubMed ID: 11123280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46.
    Spaggiari GM; Carosio R; Pende D; Marcenaro S; Rivera P; Zocchi MR; Moretta L; Poggi A
    Eur J Immunol; 2001 Jun; 31(6):1656-65. PubMed ID: 11385609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.
    Gorbachev AV; Fairchild RL
    J Immunol; 2004 Aug; 173(4):2443-52. PubMed ID: 15294958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon gamma: its role in the elicitation of an effective antitumor immune response.
    Jyothi MD; Khar A
    Cancer Immunol Immunother; 2000 Dec; 49(10):563-72. PubMed ID: 11129327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy.
    Liu Y; Wu HW; Sheard MA; Sposto R; Somanchi SS; Cooper LJ; Lee DA; Seeger RC
    Clin Cancer Res; 2013 Apr; 19(8):2132-43. PubMed ID: 23378384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
    Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
    J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of CD56+ NK and NKT-like lymphocytes from peripheral blood mononuclear cells of patients with ovarian neoplasia.
    Alves PCM; De Angelo Andrade LAL; Petta CA; Lorand-Metze I; Derchain SF; Guimarães F
    Scand J Immunol; 2011 Sep; 74(3):244-252. PubMed ID: 21595734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
    Tai YT; Li XF; Catley L; Coffey R; Breitkreutz I; Bae J; Song W; Podar K; Hideshima T; Chauhan D; Schlossman R; Richardson P; Treon SP; Grewal IS; Munshi NC; Anderson KC
    Cancer Res; 2005 Dec; 65(24):11712-20. PubMed ID: 16357183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
    Carbone E; Ruggiero G; Terrazzano G; Palomba C; Manzo C; Fontana S; Spits H; Kärre K; Zappacosta S
    J Exp Med; 1997 Jun; 185(12):2053-60. PubMed ID: 9182676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
    J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo CD40-CD154 (CD40 ligand) interaction induces integrated HIV expression by APC in an HIV-1-transgenic mouse model.
    Chougnet C; Freitag C; Schito M; Thomas EK; Sher A; Shearer GM
    J Immunol; 2001 Mar; 166(5):3210-7. PubMed ID: 11207274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
    Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
    Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors.
    Terrazzano G; Zanzi D; Palomba C; Carbone E; Grimaldi S; Pisanti S; Fontana S; Zappacosta S; Ruggiero G
    J Leukoc Biol; 2002 Aug; 72(2):305-11. PubMed ID: 12149421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.